English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduThree years ago, Jessica Sheth Bhutada, MD, was researching rates of metastatic cancer in adolescents and young adults (AYAs) when she noticed a disturbing trend.
Tag: Stomach Cancer
MD Anderson Research Highlights for August 7, 2024
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. Recent developments at MD Anderson include insights into evolutionary cellular adaptations to environmental stressors, potential targets to overcome trouble swallowing in head and neck cancer patients treated with radiation therapy, a promising chemotherapy-free combination treatment for patients with a subset of acute lymphocytic leukemia, a single-cell atlas for stomach cancer metastasis, encouraging results of a PARP inhibitor on patients with advanced cancers and specific DNA damage repair mutations, and a liquid biopsy signature that could improve early pancreatic cancer detection.
New Sylvester Study Targets Major Risk Factor for Gastric Cancer
Can we eliminate a major risk factor for stomach cancer in Black, Asian, Latino and other vulnerable populations? A new study shows the feasibility of offering high-risk communities free, accessible testing and treatment for H.pylori infection – a major risk factor for gastric cancer.
Robotic surgery expertise increases odds for those who battle stomach cancer like Toby Keith
Toby Keith, John Wayne and Fred Rogers are among many famous figures who passed from stomach cancer, a particularly deadly form of cancer. Now, robotic surgery is improving the odds for cancer patients. Matthew Porembka, M.D. is part of a…
Baylor Scott & White doctor discusses why cancer is impacting more young people
David Winter, MD, at Baylor Scott & White Health, discusses why cancer is impacting more young people. What You Need to Know: People aged 50 and older are living longer because of better cancer detection and treatments. Cancer diagnosis in…
MD Anderson Research Highlights for October 25, 2023
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
Recent developments at MD Anderson include positive results from a Phase I trial for patients with TP53-mutant acute myeloid leukemia, a novel machine learning platform to identify cancer biomarkers from liquid biopsies, a tumor-specific multi-microRNA delivery system to improve treatment outcomes in glioblastoma, a combination strategy to overcome treatment resistance in KRAS-mutated pancreatic cancer, and a new target for improving treatment response in patients with stomach cancer that has metastasized to the peritoneal cavity.
Baylor Scott & White Shares Insights At ACG Annual Scientific Meeting 2023
The 2023 American College of Gastroenterology (ACG) Annual Scientific Meeting & Postgraduate Course will convene in Vancouver, Canada, Oct. 20-25. The ACG is a recognized leader in educating GI professionals and the public about digestive disorders. The ACG’s mission is…
AI can predict certain forms of esophageal and stomach cancer
AI can predict certain forms of esophageal and stomach cancer Michigan Medicine study says.
Male hormones regulate stomach inflammation in mice
Scientists at the National Institutes of Health determined that stomach inflammation is regulated differently in male and female mice after finding that androgens, or male sex hormones, play a critical role in preventing inflammation in the stomach. The study was published in Gastroenterology.
Many younger patients with stomach cancer have a distinct disease, Mayo research discovers
Many people under 60 who develop stomach cancer have a “genetically and clinically distinct” disease, new Mayo Clinic research has discovered. Compared to stomach cancer in older adults, this new, early onset form often grows and spreads more quickly, has a worse prognosis, and is more resistant to traditional chemotherapy treatments.